Human health risk assessment of pharmaceuticals in the European Vecht River
- PMID: 35112470
- PMCID: PMC9790459
- DOI: 10.1002/ieam.4588
Human health risk assessment of pharmaceuticals in the European Vecht River
Abstract
Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occurring in the German-Dutch transboundary Vecht River. An exposure model was developed and used to assess the combined risks of oral and dermal exposure under a variety of exposure conditions. A total of 4500 API uptake values and 165 lifetime risk values were estimated for 15 and 11 APIs, respectively. Overall, the lifetime human health risks posed by the APIs and their mixtures based on modeling results were deemed acceptable under typical exposure conditions. Under very extreme environmental conditions and human behavior, API mixture risks were of potential concern while the risks of individual APIs were negligible, with a few exceptions. The antibiotic doxycycline and analgesic phenazone showed the highest and lowest risks, respectively. The study did not evaluate the potential risks caused by metabolite compounds. Recommendations for water managers are provided to help improve the accuracy and utility of human health risk assessments of pharmaceuticals. Integr Environ Assess Manag 2022;18:1639-1654. © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Keywords: Human health; Pharmaceutical; Risk assessment; Surface water.
© 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- aus der Beek, T. , Weber, F.‐A. , Bergmann, A. , Hickmann, S. , Ebert, I. , Hein, A. , & Küster, A. (2016). Pharmaceuticals in the environment—Global occurrences and perspectives. Environmental Toxicology and Chemistry, 35(4), 823–835. - PubMed
-
- Bean, T. G. , Rattner, B. A. , Lazarus, R. S. , Day, D. D. , Burket, S. R. , Brooks, B. W. , Haddad, S. P. , & Bowerman, W. W. (2018). Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay. Environmental Pollution, 232, 533–545. - PubMed
-
- Benfenati, E. , Manganaro, A. , & Gini, G. (2013). VEGA‐QSAR: AI inside a platform for predictive toxicology. CEUR Workshop, Turin, Italy, 1107, 8.
-
- Bercu, J. P. , Parke, N. J. , Fiori, J. M. , & Meyerhoff, R. D. (2008). Human health risk assessments for three neuropharmaceutical compounds in surface waters. Regulatory Toxicology and Pharmacology, 50(3), 420–427. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical